Literature DB >> 22653767

Lung function from infancy to preschool in a cohort of children with cystic fibrosis.

Lyndia C Brumback1, Stephanie D Davis, Gwendolyn S Kerby, Margaret Kloster, Robin Johnson, Robert Castile, Peter W Hiatt, Meeghan Hart, Margaret Rosenfeld.   

Abstract

This study aimed to describe lung function in a cohort of children with cystic fibrosis (CF) who underwent infant pulmonary function tests (IPFTs) and preschool spirometry. Children performed up to four IPFTs (raised volume rapid thoracic compression technique) over 1 yr and five preschool spirometry tests over up to 2 yrs during participation in prospective, multicentre studies of infant and preschool lung function. All lung function data were reviewed centrally for measurement acceptability. 45 children had 252 acceptable measurements (137 IPFTs and 115 preschool spirometries) at ages 0.3-6.5 yrs. The median number of measurements per participant was 6 (range 3-9). Recent Pseudomonas aeruginosa infection was associated with 5.1% (95% CI 0.01-9.9%) lower forced expiratory volume in 0.5 s (FEV(0.5)) and 16.4% (95% CI 7.0-24.9%) lower forced expiratory flow at 25-25% of forced vital capacity (FEF(25-75%)), after adjustment for length, test type and centre. Recent cough was associated with 5.7% (95% CI 1.1-10.1%) lower FEV(0.5) and 10.1% (95% CI 0.6-18.7%) lower FEF(25-75%). Even after accounting for infection status, cough, sex, length, test type and centre, there was significant inter-individual variability in lung function (p<0.01 for each of FEV(0.5), FEF(25-75%) and forced vital capacity). Recent P. aeruginosa infection and cough are associated with lower lung function in children with CF. Significant inter-individual variability in lung function remains to be explained.

Entities:  

Mesh:

Year:  2012        PMID: 22653767     DOI: 10.1183/09031936.00021612

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

1.  Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.

Authors:  Margaret Rosenfeld; Philip M Farrell; Margaret Kloster; Jonathan O Swanson; Thuy Vu; Lyndia Brumback; James D Acton; Robert G Castile; Andrew A Colin; Carol K Conrad; Meeghan A Hart; Gwendolyn S Kerby; Peter W Hiatt; Peter J Mogayzel; Robin C Johnson; Stephanie D Davis
Journal:  Eur Respir J       Date:  2013-05-30       Impact factor: 16.671

Review 2.  Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity.

Authors:  Daniel R Laucirica; Luke W Garratt; Anthony Kicic
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

3.  Lung inflammation and simulated airway resistance in infants with cystic fibrosis.

Authors:  Emily M DeBoer; Julia S Kimbell; Kaci Pickett; Joseph E Hatch; Kathryn Akers; John Brinton; Graham L Hall; Louise King; Fiona Ramanauskas; Tim Rosenow; Stephen M Stick; Harm A Tiddens; Thomas W Ferkol; Sarath C Ranganathan; Stephanie D Davis
Journal:  Respir Physiol Neurobiol       Date:  2021-06-19       Impact factor: 1.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.